Bionic Biologics Platform
Oncology, Neurodegeneration, Rare Diseases
Pre-clinicalActive
Key Facts
Indication
Oncology, Neurodegeneration, Rare Diseases
Phase
Pre-clinical
Status
Active
Company
About Grove Biopharma
Grove Biopharma is a private, pre-clinical-stage biotech developing a breakthrough platform for intracellular drug delivery. Its core technology, Bionic Biologics™, uses precision polymerization to create synthetic, cell-permeable polymers that can engage challenging intracellular protein-protein interaction targets. The company has demonstrated proof-of-concept across several high-value targets, including MYC and KRAS, and is backed by a $30 million Series A financing to advance its pipeline in oncology, neurodegenerative diseases, and rare disorders.
View full company profile